Decrements in Both Physical and Cognitive Function Are Associated With a Higher Symptom Burden in Oncology Patients
- PMID: 37968207
- DOI: 10.1016/j.soncn.2023.151516
Decrements in Both Physical and Cognitive Function Are Associated With a Higher Symptom Burden in Oncology Patients
Abstract
Objectives: Physical and cognitive function are two of the most important patient-reported outcomes. In oncology patients receiving chemotherapy (N = 1331), purposes were to identify subgroups of patients with distinct joint physical and cognitive function profiles and evaluate for differences in demographic and clinical characteristics, severity of common symptoms, and quality of life outcomes.
Data sources: Measures of physical and cognitive functions were obtained six times over two cycles of chemotherapy. All of the other measures were done prior to the second or third cycle of chemotherapy. Latent profile analysis was done to identify the distinct joint physical and cognitive function profiles. Differences among the profiles were evaluated using parametric and nonparametric tests.
Conclusion: Five distinct profiles were identified (ie, Very Low Physical and Low Cognitive Function [18.4%; Both Low], Low Physical and High Cognitive Function [19.8%], Moderate Physical and Low Cognitive Function [26.7%], Changing Physical and Cognitive Function [5.4%], and Normal Physical and Cognitive Function [29.7%]). Patients in the Both Low class had the highest symptom burden and the poorest quality of life. Over 70% of the sample had moderate to severe decrements in one or both of these extremely important patient outcomes.
Implications for nursing practice: Clinicians need to assess for both physical and cognitive function using simple subjective and objective measures.
Keywords: Anxiety; Cancer; Cognitive function; Cognitive impairment; Depression; Fatigue; Pain; Patient-reported outcomes; Physical function; Sleep disturbance.
Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest The authors have no competing interest to declare.
Similar articles
-
Greater Symptom Burden and Poorer Quality of Life Outcomes Are Associated With The Co-Occurrence of Anxiety and Depression During Cancer Chemotherapy.Semin Oncol Nurs. 2025 Apr;41(2):151809. doi: 10.1016/j.soncn.2025.151809. Epub 2025 Feb 13. Semin Oncol Nurs. 2025. PMID: 39952817
-
Increased Stress Is Associated With Severe Pain and Decrements in Cognitive Function in Patients Receiving Chemotherapy.Semin Oncol Nurs. 2024 Feb;40(1):151577. doi: 10.1016/j.soncn.2023.151577. Epub 2024 Jan 19. Semin Oncol Nurs. 2024. PMID: 38245388
-
Impact of worst pain severity and morning fatigue profiles on oncology outpatients' symptom burden and quality of life.Support Care Cancer. 2022 Dec;30(12):9929-9944. doi: 10.1007/s00520-022-07431-6. Epub 2022 Nov 10. Support Care Cancer. 2022. PMID: 36355215
-
Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.Health Technol Assess. 2020 Sep;24(46):1-490. doi: 10.3310/hta24460. Health Technol Assess. 2020. PMID: 32975190 Free PMC article.
-
Telephone interventions for symptom management in adults with cancer.Cochrane Database Syst Rev. 2020 Jun 2;6(6):CD007568. doi: 10.1002/14651858.CD007568.pub2. Cochrane Database Syst Rev. 2020. PMID: 32483832 Free PMC article.
Cited by
-
Palliative Care in the Ageing European Population: A Cross-Country Comparison.Int J Environ Res Public Health. 2024 Jan 19;21(1):113. doi: 10.3390/ijerph21010113. Int J Environ Res Public Health. 2024. PMID: 38276807 Free PMC article.
-
Symptom Network Analysis and Unsupervised Clustering of Oncology Patients Identifies Drivers of Symptom Burden and Patient Subgroups With Distinct Symptom Patterns.Cancer Med. 2024 Oct;13(19):e70278. doi: 10.1002/cam4.70278. Cancer Med. 2024. PMID: 39377555 Free PMC article.
-
Impact of Atezolizumab + Bevacizumab Therapy on Health-Related Quality of Life in Patients with Advanced Hepatocellular Carcinoma.Cancers (Basel). 2024 Oct 25;16(21):3610. doi: 10.3390/cancers16213610. Cancers (Basel). 2024. PMID: 39518049 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical